Author Correction: Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial
- Resource Type
- article
- Source
- Nature Communications, Vol 14, Iss 1, Pp 1-1 (2023)
- Subject
Science - Language
- English
- ISSN
- 2041-1723